Progression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP Study

Diabetes Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01034826
• Other study ID #: KNDP IGT study
• Status: Completed
• Phase: N/A
• First received: December 17, 2009
• Last updated: June 8, 2010
• Start date: February 2007
• Est. completion date: May 2010

Study information

• Verified date: December 2009
• Source: Korea University Guro Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

Impaired glucose tolerance is a metabolic state between normal glucose homeostasis and diabetes. Previously, prospective studies have shown higher progression rates from IGT to diabetes in other country. But There is no prospective-multicenter based reports in Korea. Therefore, the purpose of this study is to estimate the progression rates to impair glucose regulation and diabetes in the Korean population-based Korea national Diabetes program.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 500
• Est. completion date: May 2010
• Est. primary completion date: December 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• fastic serum glucose >100 and/or pp2 serum glucose <200

Exclusion Criteria:

• known diabetes

• organ failure(For example, liver, kidney)

• known malignancy

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Diabetes
• Glucose Intolerance
• Impaired Glucose Tolerance

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Korea University Guro Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	fasting serum glucose, fasting plasma insulin,post prandial serum glucose, post prandial plasma insulin, hbA1c		0.1.3.5 year	No